Skip to main content
. Author manuscript; available in PMC: 2013 Aug 16.
Published in final edited form as: Eur J Clin Invest. 2010 Aug 19;40(10):903–910. doi: 10.1111/j.1365-2362.2010.02347.x

Figure 3 A.

Figure 3 A

Representative Western blots of a Control, and an ESRD subject (Pre-HD and End-HD) of carboxy-terminal actin. The 2 blots demonstrate an increase in the 14kDa fragment in the ESRD patient Pre-HD and a greater increase at End-HD. All blots were loaded with the same control patient and reprobed for GAPDH to ensure equal loading across blots.